Published in Drug Law Weekly, June 9th, 2009
“We are pleased with our year end results from both a financial and operational standpoint particularly in light of the worldwide recession,” said Todd Johnson, Interim President and CEO of Accelrys. “We achieved profitability on both a GAAP and non-GAAP basis for the year and increased our cash balance by $5.4 million. We enhanced our life sciences and materials sciences offerings and released Pipeline Pilot Enterprise Server 7.5, the latest version of our industry-leading scientific operating platform. The new release includes enhanced enterprise-level...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.